首頁 > 市場調查報告書 > 醫療設備

整形外科手術用器具

市場調查報告書

商品編碼

1345446

全球脊柱後側凸市場 - 2023-2030

Global Kyphoscoliosis Market - 2023-2030

出版日期: 2023年09月06日 | 出版商:

DataM Intelligence | 英文 186 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2022年，全球脊柱後側凸市場規模達到29億美元，預計到2030年將達到42億美元，2023-2030年預測期間年複合成長率為5.1%。

脊柱後側凸是脊柱在兩個平面上的異常彎曲：冠狀面（或從一側到另一側）和矢狀面（或從後到前）。這是另外兩種疾病的綜合脊柱異常：脊柱後凸和脊柱側凸。脊柱側凸會導致冠狀面曲率異常，從而導致脊柱水平彎曲。

由於在矢狀面上不正確地向前或向後扭轉，脊柱後凸會導致背部看起來呈圓形或下垂。患者特定植入物和手術規劃工具的開發通常在 3D 列印和電腦輔助設計的幫助下，可以通過為每位患者定製手術來改善手術結果。治療選擇包括物理治療、支具治療，在嚴重的情況下還包括手術治療。這些手術旨在減少不適，同時改善姿勢和活動能力。

動力學

神經系統疾病的興起

神經系統疾病會影響肌肉控制、協調和一般神經肌肉功能，因此很容易影響脊柱後側凸的發生和演變。包括肌營養不良症和脊髓性肌萎縮症在內的神經系統疾病經常伴有肌肉無力。薄弱的肌肉無法為脊柱提供必要的支撐來維持其自然姿勢和彎曲。這種弱化可能會導致非典型的脊柱彎曲，例如脊柱後側凸。

一些神經系統疾病，例如脊髓腫瘤或創傷，可以直接壓迫脊髓或使其受傷。通過乾擾控制肌肉功能和姿勢的常規大腦脈衝，這種壓迫有可能導致脊柱異常，例如脊柱後側凸。因此，神經系統疾病的增加將推動市場成長。

例如，根據聯合國最近的一份報告，多達10 億人，即世界人口的近六分之一，患有神經系統疾病，包括偏頭痛、腦損傷和神經感染，以及阿滋海默症和帕金森氏症、中風等疾病、多發性硬化症和癲癇症。每年有 680 萬人遭受這些疾病的折磨。因此，神經系統疾病的增加促進了市場的快速擴張。

治療技術的進步

脊柱後側凸的診斷、治療和管理都極大地受益於技術進步。這些進展增加了我們對這種疾病的了解，提高了診斷能力，並提供了更好的治療選擇。

例如，一種常見的醫療設備，特別是在脊柱手術中，是 MAGEC 系統。為了減緩脊柱側凸的進展，脊柱在生長過程中受到支撐。接受這種治療的患者中，兒童患者佔很大一部分。 2020 年 2 月 13 日發布了安全通知，以回應 MAGEC 系統 Model X 桿中執行器端蓋植入後分離的投訴。數據評估顯示，約0.5%的設備發生執行器端蓋分離，促使醫生停止所有系統植入。

醫生被警告說，端蓋分離後，植入物可能會變得鬆動、腐蝕、遷移或引起疼痛，並且桿在充當內部支架時可能會繼續延伸或分散。這可能會導致執行器的內部組件暴露，從而加速其老化，並導致鈦合金、磨損碎片和局部組織變色進入系統。

與治療相關的副作用

脊柱後側凸可以通過多種方式治療，包括支具、物理治療和手術，具體取決於病情的嚴重程度和患者的具體需求。每種治療形式都有一些潛在的副作用和具體的注意事項。長時間佩戴支具可能會導致皮疹、擦傷或壓瘡。

填充和適當的貼合可以緩解這個問題。物理治療練習可能會導致肌肉酸痛，尤其是在開始新的鍛煉程序時。手術後幾週或幾個月內，患者可能會在手術部位感到疼痛和不適。疼痛控制是術後護理的重要組成部分。

如需報告的更多詳細資訊，索取樣品

Overview

Global Kyphoscoliosis Market reached US$ 2.9 billion in 2022 and is expected to reach US$ 4.2 billion by 2030, growing with a CAGR of 5.1% during the forecast period 2023-2030.

Kyphoscoliosis is an abnormal curve of the spine on two planes: the coronal plane, or side to side, and the sagittal plane, or back to front. It's a combined spinal abnormality of two other conditions: kyphosis and scoliosis. Scoliosis causes an abnormal coronal plane curvature, which causes the spine to curve horizontally.

By improperly twisting forward or backward on the sagittal plane, kyphosis causes the back to seem rounded or fell. The development of patient-specific implants and surgical planning tools, typically assisted by 3D printing and computer-assisted design, can improve surgical outcomes by customising operations for each patient. Treatment options include physical therapy, bracing, and in severe situations, surgery. These procedures aim to reduce discomfort while also improving posture and mobility.

Dynamics

The Rise of Neurological Disorders

Neurological disorders can easily influence the onset and evolution of kyphoscoliosis due to their effects on muscle control, coordination, and general neuromuscular function. Neurological diseases including muscular dystrophy and spinal muscular atrophy frequently present with muscle weakness. Weak muscles are unable to provide the spine with the necessary support to maintain its natural posture and curvature. Atypical spinal curvatures, such kyphoscoliosis, may arise as a result of this weakening.

Some neurological conditions, such as spinal cord tumours or trauma, can directly compress the spinal cord or injure it. By interfering with the regular brain impulses that control muscle function and posture, this compression has the potential to result in spinal anomalies such kyphoscoliosis. Therefore, the increase of neurological disorders will boost market growth.

For instance, according to a recent United Nations report, up to 1 billion people, or nearly one in six of the world's population, suffer from neurological disorders, including migraine, brain injuries, and neuroinfections as well as diseases like Alzheimer's and Parkinson's, stroke, multiple sclerosis, and epilepsy. Each year, 6.8 million people suffer as a result of these illnesses. Thus, the rise in neurological conditions contributes to the market's rapid expansion.

Technological Advancements in the Treatment

The diagnosis, treatment, and management of kyphoscoliosis have all benefited greatly from technological improvements. These developments have increased our understanding of the disorder, improved the capacity to diagnose it, and provided better therapy options.

For instance, a common medical device, particularly in spinal surgery, is the MAGEC system. In order to slow the progression of scoliosis, the spine is braced during growth. Paediatric patients make up a large portion of the patients receiving this treatment. A safety notice was issued on February 13, 2020, in response to complaints of post-implantation separation of an actuator end cap in MAGEC system Model X rods. The data evaluation revealed that the actuator end cap separation had happened in about 0.5% of the devices, prompting doctors to stop all system implantations.

Physicians have been cautioned that after the end cap has separated, the implant may become loose, corrode, migrate, or cause pain, and that the rod may continue to extend or distract while acting as an internal brace. This could result in the actuator's internal components becoming exposed, which could speed their deterioration and allow titanium alloy, wear debris, and localised tissue discoloration to enter the system.

Side Effects Associated with the Treatment

Kyphoscoliosis can be treated in a number of ways, including bracing, physical therapy, and surgery, depending on the severity of the condition and the patient's specific needs. There are several potential side effects and considerations specific to each form of treatment. An extended period of wearing a brace may result in skin rashes, chafing, or pressure sores.

Padding and a proper fit could mitigate this issue. Physical therapy exercises may cause muscle soreness, especially when starting a new exercise routine. Patients may experience pain and discomfort at the surgical site for several weeks or months after the procedure. Pain control is a crucial part of postoperative care.

Segment Analysis

The global kyphoscoliosis market is segmented based on type, disease management, age group, end user and region.

Kyphoscoliosis can Affect Children more Easily than Adults

Kyphoscoliosis can affect children more easily than adults due to a number of issues associated to the developing spine and musculoskeletal system during childhood and adolescence. For instance, certain children have a higher risk of developing kyphoscoliosis due to congenital spine abnormalities. These anomalies might not be identified until the child's spine begins to grow and develop.

The ligaments and soft tissues that surround the spine also grow swiftly in children and teenagers. These structures may not develop properly or expand at different rates, which can cause kyphoscoliosis. Children and teenagers are more likely to participate in activities that strain the spine excessively or adopt poor postural habits. Large backpacks, protracted use of electronic gadgets while hunched over, and various badly performed tasks can strain the spine and possibly result in kyphoscoliosis. Thus, all of those factors contribute to accelerating segment expansion.

Geographical Penetration

Rising Product Approvals and Prevalence of Disease in the North American Region

A mix of historical, economic, and societal factors have contributed to the great advancement of healthcare services in North America, especially in the United States and Canada. In North America, regulatory organisations like the Food and Drug Administration (FDA) in the United States and Canada set strict guidelines for the effectiveness and safety of medications and medical devices. These organisations aid in ensuring that only secure and efficient medications are distributed.

Moreover, numerous medical research organisations, academic institutes, and healthcare facilities located in North America are at the forefront of spine-related research. To learn more about the origins, risk factors, and available treatments for kyphoscoliosis, researchers in the area are actively researching the condition. Clinical trials are required because of this area of research interest. North America is the perfect site for conducting clinical trials due to its sophisticated healthcare system and medical technologies. Clinical research can be carried out with the help of modern facilities, qualified medical personnel, and advanced imaging technology. Thus, all of these variables contribute to the region's growth.

COVID-19 Impact Analysis

Many healthcare systems had issues and delays in non-urgent care during the pandemic, including the diagnosis and treatment of kyphoscoliosis. Routine tests, imaging, and elective treatments were postponed or cancelled in a number of locations, which would have delayed the diagnosis and treatment of some patients.

Patients who rely on orthopaedic braces for their kyphoscoliosis therapy may have experienced difficulties getting their braces fitted, adjusted, or replaced when hospitals cut back on their services or during lockdowns. This could impact the effectiveness of bracing therapies. During periods of high COVID-19 activity, elective treatments, such as those to treat kyphoscoliosis, were routinely delayed to save money on medical services and reduce the risk of viral transmission in hospitals. As a result, individuals who require surgery could have to wait longer.

By Type

Scoliosis
Kyphosis
- Postural kyphosis
- Scheuermann's kyphosis
- Age-related kyphosis
- Congenital kyphosis

By Disease Management

Diagnosis
- MRI
- CT Scan
- Bone Density Testing
- Others

Medication
Surgery
- Spinal Implants
- Bone Grafts
- Braces and Orthotics
- Others

By Age Group

Children
Adults

By End User

Hospitals
Clinics
Ambulatory Surgical Centers

By Region

North America
- U.S.
- Canada
- Mexico

Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe

South America
- Brazil
- Argentina
- Rest of South America

Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific

Middle East and Africa

Key Developments

On July 05, 2022, an advanced surgery was recently performed by a skilled team of surgeons from the city's top multispecialty hospital, SIMS Hospital India, to treat a severe case of kyphoscoliosis. The spine surgery community refers to the 15-year-old Ethiopian patient, Master Tesfaye Mengesha Mersha, who has severe kyphoscoliosis, as having a "Anaconda Spine," a 110-degree deformity of the upper spine in the chest area.
On September 22, 2021, the first surgical procedure in the BRAIVE IDE study, which will assess the safety and efficacy of the BraiveTM growth modulation system for the treatment of progressive juvenile (JIS) or adolescent (AIS) idiopathic scoliosis, has been completed, according to Medtronic plc, the world leader in medical technology.

Competitive Landscape

The major global players in the market include Koninklijke Philips N.V., Canon, GE Healthcare, Siemens, Hologic, Sri Krishna Pharmaceuticals Ltd, NEXGEN PHARMA INC, ValiantLabs.in., BASF Corporation, Dr. Reddy's Laboratories Ltd and among others.

Why Purchase the Report?

To visualize the global kyphoscoliosis market segmentation based on type, disease management, age group, end user and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of kyphoscoliosis market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global kyphoscoliosis market report would provide approximately 61 tables, 58 figures and 186 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Disease Management
3.3. Snippet by Age Group
3.4. Snippet by End User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. The rise of Neurological disorders
  - 4.1.1.2. Technological advancements in the Treatment
4.2. Restraints
- 4.2.2. Opportunity
- 4.2.3. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 7.1.2. Market Attractiveness Index, By Type
7.2. Scoliosis *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Kyphosis
- 7.3.1. Postural kyphosis
- 7.3.2. Scheuermann's kyphosis
- 7.3.3. Age-related kyphosis
- 7.3.4. Congenital kyphosis

8. By Disease Management

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Management
- 8.1.2. Market Attractiveness Index, By Disease Management
8.2. Diagnosis*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  - 8.2.2.1. MRI
  - 8.2.2.2. CT Scan
  - 8.2.2.3. Bone Density Testing
  - 8.2.2.4. Others
8.3. Medication
8.4. Surgery
- 8.4.1. Spinal Implants
- 8.4.2. Bone Grafts
- 8.4.3. Braces and Orthotics
- 8.4.4. Others

9. By Age Group

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 9.1.2. Market Attractiveness Index, By Age Group
9.2. Children*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Adults

10. By End User

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.1.2. Market Attractiveness Index, By End User
10.2. Hospitals*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Clinics
10.4. Ambulatory Surgical Centres

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.6.1. U.S.
  - 11.2.6.2. Canada
  - 11.2.6.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Management
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.7.1. Germany
  - 11.3.7.2. UK
  - 11.3.7.3. France
  - 11.3.7.4. Italy
  - 11.3.7.5. Spain
  - 11.3.7.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Management
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.7.1. Brazil
  - 11.4.7.2. Argentina
  - 11.4.7.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Management
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.7.1. China
  - 11.5.7.2. India
  - 11.5.7.3. Japan
  - 11.5.7.4. Australia
  - 11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Management
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles (1-5 Diagnosis Device Manufacturers & 6-10 Drug Manufacturers)

13.1. Koninklijke Philips N.V. *
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. Canon
13.3. GE Healthcare
13.4. Siemens
13.5. Hologic
13.6. Sri Krishna Pharmaceuticals Ltd
13.7. NEXGEN PHARMA INC
13.8. ValiantLabs.in.
13.9. BASF Corporation
13.10. Dr. Reddy's Laboratories Ltd

LIST NOT EXHAUSTIVE